Company news

ADMA Biologics Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ADMA Biologics Announces First Commercial Sales of ASCENIV™

October 20, 2019

ADMA Biologics Announces Publication of an Article Describing the Manufacturing Process Optimization for its Commercial Products BIVIGAM® and ASCENIV™ in the Peer Reviewed Journal Immunotherapy

October 16, 2019

ADMA Biologics Announces Data Presented at IDWeek 2019

October 6, 2019

ADMA Biologics Announces Poster Presentation at IDWeek 2019

October 2, 2019

ADMA Biologics to Present at 2019 Cantor Global Healthcare Conference

September 22, 2019

ADMA Receives Department of Health and Human Services U.S. License

April 1, 2019

FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin

March 31, 2019

← Newer news releases

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 23 decks. Every deck is listed under its year.